文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.

作者信息

Xue Xingting, Zhou Hongbing, Gao Jiaxing, Li Xinghua, Wang Jia, Bai Wanfu, Bai Yingchun, Fan Liya, Chang Hong, Shi Songli

机构信息

Department of Pharmacy, Baotou Medical College, Baotou, 014040, China.

Changzhi People's Hospital, The Affiliated Hospital of Changzhi Medical College, Changzhi, Shanxi Province, China.

出版信息

Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.


DOI:10.1016/j.heliyon.2024.e38339
PMID:39391468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466535/
Abstract

Traditional Chinese medicine (TCM) and dietary compounds have a profound influence on the regulation of gut microbiota (GM) in hepatic fibrosis (HF). Certain substances found in both food and herbs that are edible and medicinal, such as dietary fiber, polyphenols, and polysaccharides, can generate beneficial metabolites like short-chain fatty acids (SCFAs), bile acids (BAs), and tryptophan (Trp). These compounds contribute to regulate the GM, reduce levels of endotoxins in the liver, and alleviate fibrosis and inflammation in the liver. Furthermore, they enhance the composition and functionality of GM, promoting the growth of beneficial bacteria while inhibiting the proliferation of harmful bacteria. These mechanisms mitigate the inflammatory response in the intestines and maintain the integrity of the intestinal barrier. The purpose of this review is to analyze how the GM regulates the pathogenesis of HF, evaluate the regulatory effect of TCM and dietary compounds on the intestinal microflora, with a particular emphasis on modulating flora structure, enhancing gut barrier function, and addressing associated pathogenic factors, thereby provide new insights for the treatment of HF.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/d3658506d15b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/3284c03ddfde/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/4ef4dba14cdc/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/ee4e853e6141/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/86c092ac0c1f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/4919fcd8f34d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/d3658506d15b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/3284c03ddfde/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/4ef4dba14cdc/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/ee4e853e6141/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/86c092ac0c1f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/4919fcd8f34d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d99/11466535/d3658506d15b/gr5.jpg

相似文献

[1]
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.

Heliyon. 2024-9-26

[2]
Bile acids metabolism involved in the beneficial effects of Danggui Shaoyao San via gut microbiota in the treatment of CCl induced hepatic fibrosis.

J Ethnopharmacol. 2024-1-30

[3]
Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota.

Crit Rev Food Sci Nutr. 2018-12-20

[4]
Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.

Phytother Res. 2022-11

[5]
Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder.

Biomed Pharmacother. 2022-7

[6]
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology.

J Ethnopharmacol. 2024-1-10

[7]
Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.

Microbiol Spectr. 2024-6-4

[8]
Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?-a narrative review.

Ann Palliat Med. 2021-4

[9]
An overview of traditional Chinese medicine affecting gut microbiota in obesity.

Front Endocrinol (Lausanne). 2023

[10]
Dietary glycation compounds - implications for human health.

Crit Rev Toxicol. 2024-9

引用本文的文献

[1]
Bioactive Compounds and Antioxidant Activity of , , in the Context of Environmental Conditions and Heavy Metals Bioaccumulation.

Molecules. 2025-8-5

[2]
Dietary Fiber Intake Improves Osteoporosis Caused by Chronic Lead Exposure by Restoring the Gut-Bone Axis.

Nutrients. 2025-4-29

[3]
The Role of Gut Microbiota on Intestinal Fibrosis in Inflammatory Bowel Disease and Traditional Chinese Medicine Intervention.

J Inflamm Res. 2025-5-7

[4]
Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance.

Front Pharmacol. 2025-1-24

本文引用的文献

[1]
Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis.

Int Immunopharmacol. 2024-9-30

[2]
A study on the treatment effects of polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota.

Front Vet Sci. 2024-3-27

[3]
Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications.

Front Pharmacol. 2024-2-29

[4]
Yin Yang 1 facilitates the activation, inflammation, and extracellular matrix deposition of hepatic stellate cells in hepatic fibrosis.

Pathol Int. 2024-4

[5]
Gut microbiome-metabolome interactions predict host condition.

Microbiome. 2024-2-10

[6]
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome.

Diabetes Metab J. 2024-3

[7]
Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-κB and TGF-β1/Smads pathways.

J Ethnopharmacol. 2024-3-25

[8]
Gut liver brain axis in diseases: the implications for therapeutic interventions.

Signal Transduct Target Ther. 2023-12-6

[9]
Galangin: A food-derived flavonoid with therapeutic potential against a wide spectrum of diseases.

Phytother Res. 2023-12

[10]
Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.

Front Endocrinol (Lausanne). 2023

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索